{"id":"W2601149910","doi":"10.1200/jco.2012.30.15_suppl.10010","title":"Phase III, placebo-controlled trial (SUCCEED) evaluating ridaforolimus as maintenance therapy in advanced sarcoma patients following clinical benefit from prior standard cytotoxic chemotherapy: Long-term (≥ 24 months) overall survival results.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Clinical endpoint; Placebo; Adverse effect; Oncology; Population; Tolerability; Randomized controlled trial; Surgery; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01873848,0.0005147567,0.00550553,0.0002280135,0.0001210595,0.00003903878,0.0004737919,0.0007993631,0.000174376],"category_scores_gemma":[0.01383022,0.0003612493,0.003358379,0.0002096192,0.0001914722,0.0004739367,0.0001040281,0.002217104,0.00001570417],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004562255,"about_ca_system_score_gemma":0.001516167,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004897917,"about_ca_topic_score_gemma":0.00006917967,"domain_scores_codex":[0.9874821,0.001432989,0.007990154,0.0006130502,0.001501562,0.0009802006],"domain_scores_gemma":[0.9865081,0.00654396,0.004706587,0.0005966384,0.0006424023,0.001002272],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6192189,0.009802876,0.1621087,0.000006059827,0.001054992,0.000398119,0.0001958301,0.000008823467,0.0002212173,0.000008984449,0.0001477095,0.2068278],"study_design_scores_gemma":[0.7002611,0.05068521,0.245967,0.0003303547,0.0004122334,0.00002801132,0.00005744007,0.0001668512,0.00006859816,0.0001902738,0.001562997,0.0002698801],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9864024,0.001391149,0.0000855614,0.001750531,0.006575041,0.003181831,0.00002553748,0.00002921576,0.0005587448],"genre_scores_gemma":[0.9881278,0.001547647,0.002851479,0.002432171,0.004640805,0.00005239258,0.00003210557,0.00008315709,0.000232457],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2065579,"threshold_uncertainty_score":0.9998839,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08738783735493295,"score_gpt":0.4617867327801262,"score_spread":0.3743988954251932,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}